Denver – A study of decisions made by the Denver District Attorney’s Office said that blacks and Spaniards accused of crimes in Denver face a “persistent set of flaws” compared to their white peers.
The study found that white people facing drug charges were more likely than blacks or Hispanics to be referred to drug court programs and that white defendants were twice as likely as blacks or Hispanics to have their cases deferred. Case deferral allows defendants to press charges or dismiss entire cases if certain requirements are met.
The researchers also found that charges against blacks were more likely to be dropped than charges against whites or Hispanics, meaning that more blacks were facing charges as plaintiffs later found there was not enough evidence to support the charges. You did not find any racial disparities in the plea agreements.
studying, Racial disparities in the outcome of the claim, Released Wednesday after being commissioned by Denver County Attorney Beth McCann in 2019. It was funded by the Government Evaluation and Action Lab at the University of Denver.
“When examined together, the results of this study show the continuing set of flaws that black and Hispanic defendants face in the criminal justice system, California,” said Stacy Busic, study author and dean of undergraduate and graduate studies at Sonoma State University near Santa Rosa.
Bosick and researchers analyzed more than 5,800 felony cases filed between July 2017 and June 2018, and interviewed 20 Denver prosecutors. The study covered dismissals, postponement of sentences, plea agreements, and referral to the drug court.
Busic made recommendations to address the inequality, including giving prosecutors more time to review the evidence and providing additional training and discussions on topics such as implicit bias. It also suggested further data collection and analysis.
“This study is being presented to prosecutors’ offices across the state as a catalyst for serious debate and to study fairness in the criminal justice system,” said McCann, who pledged to implement the proposed changes to the study.